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Abstract
The human chemokine superfamily currently includes at least 46 ligands, which bind to 18
functionally signaling G-protein-coupled receptors and two decoy or scavenger receptors. The
chemokine ligands probably comprise one of the first completely known molecular superfamilies.
The genomic organization of the chemokine ligand genes and a comparison of their sequences
between species shows that tandem gene duplication has taken place independently in the mouse
and human lineages of some chemokine families. This means that care needs to be taken when
extrapolating experimental results on some chemokines from mouse to human.
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The chemokine superfamily includes a large number of
ligands that bind to a smaller number of receptors [1,2]. The
best known function of the chemokines is the regulation of
migration of various cells in the body, hence their name
(from ‘chemotactic cytokines’). The importance of the
chemokines has grown in recent years, as it has become rec-
ognized that they are key players in many disease processes,
including inflammation, autoimmune disease, infectious
diseases (such as HIV/AIDS), and more recently, cancer (in
particular in regulating metastasis) [3]. Multiple chemokine
ligands can bind to the same receptor; the perceived com-
plexity and promiscuity of receptor binding has often made
this field a challenge to understand and given the impres-
sion that chemokines lack specific effects. We have now,
however, probably identified most human chemokine
ligands. The chemokines are small peptides, whereas their
receptors are class A G-protein-coupled receptors. They are
best known from mammals, but chemokine genes have also
been found in chicken, zebrafish, shark and jawless fish
genomes, and possible homologs of chemokine receptors
have been reported in nematodes. Careful analysis of the
members of the superfamily and their receptors shows a
logical order to its genomic organization and function,
which in turn is the result of evolutionary pressures. Here,
we provide a global view of the chemokine and chemokine
receptor superfamilies, focusing particularly on the relation-
ship between their evolution and their functions.
The chemokine ligand and receptor superfamilies
As shown in Table 1, there are at least 46 chemokine ligands
in humans. There are also 18 functionally signaling chemo-
kine receptors (plus one, CXCR7, which has been recently
reported as a potential chemokine receptor) and two ‘decoy’
or ‘scavenger’ receptors, DARC and D6, which are known to
bind several chemokines but do not signal; their function
may be to modulate inflammatory responses through their
ability to remove chemokine ligands from inflammatory
sites. In the second half of the 1990s, a large number of new
ligands were discovered following the growth of expressed
sequence tag (EST) databases. The chemokines were easy to
recognize from their characteristic structure, containing
several (usually four) cysteines in conserved positions, as
well as from their relatively small size (8-14 kDa) and from
the fact that they are produced in very large amounts by the
cells that produce them. Their high expression levels may be
due to the way they function, by establishing concentration
gradients along which the responding cells migrate. The243.2 Genome Biology 2006, Volume 7, Issue 12, Article 243 Zlotnik et al. http://genomebiology.com/2006/7/12/243
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Table 1 
The chemokine superfamily
Other Chromo- Other  Chromo-
Human names some Function Cluster Mouse names some Function Cluster Receptor
CXC family
CXCL1 Gro 4q13.3 I GRO Cxcl1* Gro/KC 5qE2 I GRO CXCR2, CXCR1
CXCL2 Gro 4q13.3 I GRO Cxcl2* MIP-2 5qE2 I GRO CXCR2
CXCL3 Gro 4q13.3 I GRO Gm1960* Dcip1 5qE2 I GRO CXCR2
CXCL4 PF4 4q13.3 U GRO Cxcl4* PF4 5qE2 U GRO CXCR3B†
CXCL4V1 4q13.3 U GRO
CXCL5 ENA-78 4q13.3 I GRO Cxcl5* LIX 5qE2 I GRO CXCR2
CXCL6 GCP-2 4q13.3 I GRO CXCR1, CXCR2
CXCL7 NAP-2 4q13.3 I GRO Cxcl7 Ppbp 5qE2 I GRO Unknown
CXCL8 IL-8 4q13.3 I GRO Unknown CXCR1, CXCR2
CXCL9 MIG 4q21.1 I IP10 Cxcl9 MIG 5qE3 I IP10 CXCR3, 
CXCR3B
CXCL10 IP-10 4q21.1 I IP10 Cxcl10 IP-10 5qE3 I IP10 CXCR3, 
CXCR3B
CXCL11 I-TAC 4q21.1 I IP10 Cxcl11 I-TAC 5qE3 I IP10 CXCR3, 
CXCR3B, 
CXCR7‡
CXCL12 SDF-1/ 10q11.21 H Cxcl12 SDF-1/ 6qF1 H CXCR4, 
CXCR7‡
CXCL13 BLC, BCA-1 4q21.1 H IP10 Cxcl13 BLC, BCA-1 5qE3 H IP10 CXCR5
CXCL14 BRAK, Bolekine 5q31.1 I Cxcl14 BRAK 13qB2 I Unknown
Unknown Cxcl15 Lungkine, 5qE2 U Unknown
Weche
CXCL16 17p13.2 I Cxcl16 Cxcl16 11qB4 I CXCR6
CXCL17 DMC 19q13.2 U Cxcl17 DMC 7qA3 U Unknown
CC family
CCL1 I-309 17q11.2 I MCP Ccl1 TCA-3 11qB5 I MCP CCR8
CCL2 MCP-1 17q11.2 I MCP Ccl2 JE 11qB5 I MCP CCR2
CCL3 MIP-1, LD78 17q11.2 I MIP Ccl3* MIP-1 11qB5 I MIP CCR1, CCR5
CCL3L1 LD78 17q12 I MIP
CCL3L3 LD78 17q12 I MIP
CCL4 MIP-1 17q12 I MIP Ccl4* MIP-1 11qB5 I MIP CCR5
CCL4L1 AT744.2 17q12 I MIP
CCL4L2 17q12 I MIP
CCL5 RANTES 17q12 I Ccl5 RANTES 11qB5 I CCR1, CCR3, 
CCR5
CCL7 MCP-3 17q11.2 I MCP Ccl7 MARC 11qB5 MCP CCR1, CCR2, 
CCR3
CCL8 MCP-2 17q11.2 I MCP Ccl8*, Ccl12* MCP-2,  11qB5 I MCP CCR1, CCR2, 
MCP-5 CCR3, CCR5
CCL11 Eotaxin 17q11.2 I MCP Ccl11 Eotaxin 11qB5 I MCP CCR3
Continued on the next pagemost recent human chemokine ligand to be reported
(CXCL17, also called dendritic and monocyte chemokine-like
protein, DMC) was found by fold-recognition methods [4].
The members of the human and mouse chemokine super-
family are listed in Table 1, together with their receptors,
and shown in schematic form in Figure 1; phylogenetic
trees for the two superfamilies are shown in Figure 2. The
two main chemokine ligand superfamiles are named
according to the arrangement of the (typically four)
cytokines within them: in the CC family, the first two cys-
teines near the amino terminus are adjacent, whereas in
the CXC family there is one amino acid between them. The
human molecules are represented using capital letters,
whereas the mouse molecules use lower case, and an L or R
is added to indicate ligand or receptor, respectively. For
example, CCL5 is the human ortholog of a chemokine pre-
viously known as RANTES, Ccl5 is its mouse ortholog and
CCR5 is a human receptor for several CCL ligands. Ligands
encoded at a given chromosomal location, shown in the
same color in Figure 1, usually bind the same receptor.
Some chemokines are produced in very large amounts by
many different cell types (for example, CCL2, CCL3 and
CCL5), whereas others can have very high specificity for par-
ticular tissues or cell types, such as CCL25 (thymus and
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Table 1 (continued from the prevoiuus page)
The chemokine superfamily
Other Chromo- Other  Chromo-
Human names some Function Cluster Mouse names some Function Cluster Receptor
CCL13 MCP-4 17q11.2 I MCP Unknown MCP CCR1, CCR2, 
CCR3
CCL14 HCC-1 17q12 H MIP Unknown CCR1
CCL15 HCC-2 17q12 H MIP Ccl9 MMRP2, CCF18,  11qB5 H MIP CCR1, CCR3
MIP-1
CCL16 HCC-4 LEC 17q12 H MIP Pseudogene 11qB5 MIP CCR1, CCR2, 
CCR5, HRH4§
CCL17 TARC 16q13 D MIP Ccl17 TARC 8qC5 D CCR4
CCL18 PARC 17q12 H Pseudogene Unknown
CCL19 MIP3, ELC 9p13.3 H Ccl19 MIP3 4qB1 H CCR7
CCL20 MIP3, LARC 2q36.3 D Ccl20 MIP3, LARC 1qC5 D CCR6
CCL21 SLC 9p13.3 D Ccl21a, Ccl21b,  SLC 4qB1 D CCR7
Ccl21c*
CCL22 MDC 16q13 D Ccl22 ABCD-1 8qC5 D CCR4
CCL23 MPIF-1 17q12 I MIP Ccl6 C10 11qB5 I MIP CCR1, FPRL-1¶
CCL24 Eotaxin 2 7q11.23 I Ccl24 Eotaxin 2 5qG1 I CCR3
CCL25 TECK 19p13.2 H Ccl25 TECK 8qA1.2 H CCR9
CCL26 Eotaxin 3 7q11.23 I Ccl26l Eotaxin 3-like 5qG1 I CCR3
CCL27 CTACK, ILC,  9p13.3 H Ccl27a,b* CTACK, ILC 4qB1 H CCR10
CCL28 MEC 5p12 U Ccl28 MEC 13 U CCR10,CCR3
Other classes
XCL1 Lymphotactin, SCM-1 1q24.2 D Xcl1* Lymphotactin 1qH2 D XCR1
XCL2 SCM-1 1q24.2 D
CX3CL1 Fractalkine 16q13 I Cx3cl1 Fractalkine 8qC5 I CX3CR1
Functions are as follows: I, inflammatory; H, homeostatic; D, dual (homeostatic and inflammatory); U, unknown. The lists of alternative names are not
comprehensive. Chromosomal location data are derived from the Ensembl [39] or Mouse Genome Informatics [40] databases. GRO, GRO region of the
CXC major gene cluster; IP10, IP10 region of the CXC major gene cluster; MCP, MCP region of the CC major gene cluster; MIP, MIP region of the CC
major gene cluster. *See also Figure 2. †An alternatively spliced variant of CXCR3 that has been reported to mediate the ability of CXCL4, CXCL9,
CXCL10 and CXCL11 to control angiogenesis. ‡Binding has been reported, but signalling is still controversial. §CCL16 has been reported to bind and
signal through histamine receptor type 4. ¶A splice variant of CCL23 has been reported to bind to and signal through formyl peptide receptor like-1
(FPRL-1).intestine), CCL27 (skin keratinocytes), CCL28 (certain
mucosal epithelial cells) or CXCL17 (stomach and trachea).
Other important aspects that differ between chemokines
include their biological activities, the regulation of their
expression, their receptor-binding specificities and the chromo-
somal locations of the genes that encode them. These fea-
tures of the chemokine superfamily have been determined
by the forces that have shaped their molecular evolution.
Linking the evolution and function of chemokines
Classification, clustering and gene duplication
The chemokines have been divided into two major groups
based on their expression patterns and functions - a useful
division, though oversimplified. Those that are expressed by
cells of the immune system (leukocytes) or related cells
(epithelial and endothelial cells, fibroblasts and so on) only
upon activation belong to the ‘inflammatory’ class, whereas
those that are expressed in discrete locations in the absence
of apparent activating stimuli have been classified as ‘homeo-
static’ (Table 1). The genomic organization of chemokines
(Table 1, Figure 3) also enables us, however, to divide
chemokines into two alternative groups: those whose genes
are located in large clusters at particular chromosomal loca-
tions (the ‘major-cluster’ chemokines; Figure 3a) and the
‘non-cluster’ or ‘mini-cluster’ chemokines whose genes are
located separately in unique chromosomal locations
(Figure 3b,c) [2]. There are two major clusters of CC
chemokine genes and two of CXC genes, plus numerous non-
clustered or mini-cluster genes of both types, in both the
mouse and human genomes (Figure 3).
An explanation for this chromosomal arrangement is found
in the evolutionary forces that have shaped the genome into
gene superfamilies [5]. Over the course of evolution, gene
duplication has been a common event, affecting most gene
families [6]. Once a duplication occurs, the two copies can
evolve independently and develop specialized functions.
This explains the origin of the cluster chemokines, which
show two other characteristics that do not apply to the non-
cluster or mini-cluster chemokines: first, the members of a
given gene cluster usually bind to multiple receptors and
vice versa (the complex and promiscuous ligand-receptor
relationships; Figure 1); and second, cluster chemokines
243.4 Genome Biology 2006, Volume 7, Issue 12, Article 243 Zlotnik et al. http://genomebiology.com/2006/7/12/243
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Figure 1
A simplified diagram of the human chemokine superfamily, arranged by the receptors they bind to. Chemokines are represented by only their ligand
number, and the receptor name also indicates whether each ligand is a CC or CXC; for example, the ‘6’ adjacent to ‘CXCR1’ represents CXC6. The
colors represent the chromosomal location of the ligands: the genes encoding the ligands shown in the same color are at the same chromosomal
location. It can be seen that ligands whose genes are located in the same chromosomal location tend to bind to the same receptor. The extra lines
attached to CXCL16 and CX3CL1 mean that these proteins exist as transmembrane proteins.
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Figure 2
Sequence relationship analysis of the human (h) and mouse (m) (a) chemokines and (b) chemokine receptors. Phylogenetic trees were constructed using
amino acid sequences with Clustal X and PAUP* (the neighbor joining method) programs [37]. In (a), the GRO and IP10 groups of CXC chemokines and
the MCP and MIP groups of CC chemokines (see also Figure 3) are circled. Red letters indicate proteins that are found in only mouse or human but not
the other. Blue letters indicate proteins for which the relationships are uncertain.
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Figure 3
Schematic genomic organization of the human and mouse chemokine superfamily. (a) Major-cluster chemokines; (b) mini-cluster chemokines; (c) non-
cluster chemokines. Solid arrows indicate chemokine genes and their transcriptional orientation; red, green and pink arrows indicate inflammatory,
homeostatic and dual function chemokine genes, respectively, and gray arrows indicate pseudogenes. Duplication units in the major clusters are indicated
by open yellow arrows. This figure is based on the NCBI 36 and 35 assemblies of the human and mouse genomes [38]. A gap indicates a region not yet
covered by the genome sequencing consortiums, while a dashed line denotes a similar region of more than 1 Mb.
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1.6 Mboften do not correspond well between species (for example,
between human and mouse) [2].
These two characteristics can be explained as follows: the
cluster chemokines and their receptors multiplied from their
ancestral genes by a series of tandem gene-duplication
events that occurred relatively recently in evolutionary
terms, that is, even after the branching of human and mouse
[2]. This is apparent from the phylogenetic tree shown in
Figure 2, in which the cluster chemokines form compact
clusters termed groups: the monocyte chemotactic protein
(MCP) group, the macrophage inflammatory protein (MIP)
group (both of CC chemokines), and the GRO group and the
IP-10 group (both of CXC chemokines). This common evolu-
tionary origin suggests that the cluster chemokines are a
group of proteins sharing a common primary function. In
the case of the chemokines encoded by the CXC GRO cluster
on chromosome 4, which in  human includes CXCL1-CXCL8,
the primary function is the regulation of neutrophil recruit-
ment to inflammatory sites [7]. The chemokines in this
cluster do this through interaction with CXCR1 and CXCR2
(Table 1, Figure 1). Similarly, the main function of the
cytokines encoded in the MIP and MCP clusters of CC
chemokines in human chromosome 17, which includes
CCL1-CCL16, CCL18 and CCL23, is the recruitment of mono-
cytes, subsets of T cells, eosinophils, and so on, to sites where
inflammation is developing, through their interaction with
CCR1, CCR2, CCR3 and/or CCR5 (Table 1, Figure 1).
Functional reasons for clustering
An explanation for the large number of ligands for these
receptors is that, during inflammation, multiple chemokines
can be needed to induce a robust leukocyte response [2].
Furthermore, differential expression of these chemokines
among different tissues may finely orchestrate the recruit-
ment of leukocytes to the tissues and could enable a ‘cus-
tomization’ of the inflammatory responses. Accordingly,
most cluster chemokines belong to the inflammatory cate-
gory [2].
Clustering and its consequences could provide a critical sur-
vival advantage to a species faced with a particular infectious
agent. For example, CCR5 expression has recently been
shown to be pivotal in resistance to infection with the West
Nile virus in humans [8]. The protective mechanism of CCR5
may involve directing leukocytes to the brain, where they
can fight the infection more effectively [9]. Another hypothe-
sis, however, involves ‘viral’ chemokines, believed to be
mammalian genes that were at some point ‘hijacked’ by
viruses. To cope with the proliferation of such viral chemo-
kines, mammals may have increased the numbers of their
own endogenous chemokines to circumvent the effects of the
viral molecules. For example, humans have CCL3L1 and
CCL4L genes, which are homologs of CCL3 and CCL4 [10]
and are found in a unit of zero to three copies depending on
the individual (Figure 3a); CCL3L1 has an affinity for CCR5
ten times higher than that of CCL3 [11]. This higher affinity
ligand would give an evolutionary advantage for an organ-
ism when coping with viral infections.
These hypotheses also explain the lack of correspondence
between cluster chemokine ligands in mouse and human,
which may reflect the ‘infectious experience’ of the two
species after they separated. This effect is shown graphically
in the separation of the human and mouse chemokine clus-
ters in the phylogenetic tree shown in Figure 2: in the groups
of chemokines there is often no one-to-one correspondence
between human and mouse genes or the relationships
between them may be uncertain. This evolution is ongoing,
and it is therefore possible that variations in these genes will
be documented even among relatively close species.
The only CC cluster chemokine that has a one-to-one ligand/
receptor relationship (with CCR8) is CCL1 (Figure 1, Table 1).
Its specific receptor, CCR8, is expressed by monocytes,
activated helper Th2 cells and natural killer T cells, CD4+
thymocytes [12], regulatory T cells [13], normal skin-homing
T cells [14], skin-homing  T cells and CD56+ CD16- natural
killer cells [15]. The CCL1 gene is located in the MCP sub-
region (Figure 3a) but is rather distantly related to other
members of the MCP group (Figure 2a), suggesting that it
was generated much earlier than the rest of the cluster
chemokines in this region. In fact, CCL1 may represent an
early chemokine that branched before the CC cluster chemo-
kines in the phylogenetic tree (Figure 2a). It is therefore pos-
sible that this chemokine-receptor pair has specific roles in
shaping the immune system [16] and, in this context, its
expression by T regulatory cells [13] is intriguing.
Non-cluster and mini-cluster chemokines
By contrast, the non- cluster or mini-cluster chemokines are
relatively conserved between species and tend not to act on
multiple receptors (Table 1, Figure 1). Indeed, several of
these have a single ligand-receptor relationship, such as
CCL25-CCR9 or CXCL13-CXCR5. The evolutionary model
described above predicts that these particular chemokine
ligand-receptor pairs probably have pivotal roles in the
development of the organism or in the function of physiolog-
ical systems necessary for the organism’s survival to repro-
ductive age (in other words, they are under evolutionary
pressure). In support of this hypothesis, the genes for most
homeostatic chemokines are found in non-cluster chromo-
somal locations (Table 1, Figure 3b,c). For example, CXCR4-
deficient and CXCL12-deficient mice both have a lethal
phenotype, and their embryos have various defects in critical
organs, such as the heart, brain or bone marrow [17]. There-
fore, throughout evolution, several non-cluster chemokines
have participated in organogenesis, and their critical func-
tions must be conserved in order for the species to survive.
Another example is the CXCL13-CXCR5 pair, which is
pivotal for successful B cell homing and, because it regulates
T cell-B cell interactions, for the production of antibodies
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these genes by preventing them from diverging from their
original function.
Early chemokines
In contrast to the cluster chemokines, the non-cluster and
mini-cluster chemokines have been conserved throughout
evolution and are therefore thought to be more ‘ancestral’
genes. This prediction is also supported by the phylogenetic
tree shown in Figure 2, in which non-cluster and mini-
cluster chemokines branch much earlier than the major-
cluster chemokines and each human chemokine of this type
has a clearly identifiable mouse counterpart [2]. There are
data to support this model. Two groups have reported that,
in the zebrafish, the CXCL12-CXCR4 pair regulates the
homing of primordial germ cells to the gonads, where they
differentiate into gametes [19,20]. Importantly, the
G-protein-coupled receptor Odysseus is readily recognizable
as the zebrafish ortholog of CXCR4; 61% of the amino acid
residues are identical between the zebrafish and human
sequences (Figure 4). Similarly, the zebrafish ortholog of
CXCL12 (with a remarkable 47% of residues in the coding
region being identical; Figure 4) is also easy to identify.
The zebrafish genome contains many other chemokine
genes, including those with the GenBank accession numbers
NM131627 and NM131062 [21], yet, in contrast to CXCL12,
the correspondence of these molecules with human chemo-
kines is not easy to establish. These observations underscore
the importance of the CXCR4-CXCL12 pair throughout ver-
tebrate evolution. GenBank now includes many chemokine
gene entries from various genomes, including many mammals,
shark, fish (including zebrafish) and even what may be
homologs of chemokine receptor genes in Caenorhabditis
elegans  [22]. Another notable example is the chemokine
LFCA-1 identified from the genome of the river lamprey (a
jawless fish), which shows 46-49% identity to the chicken
orthologs of CXCL8, K60 and 9E3 [23], and also has homol-
ogy with human CXCL8 (Figure 4).
This interspecies genomic analysis will eventually help us
understand the evolutionary history of the chemokine super-
family and may even allow us to identify a ‘primordial’
chemokine gene. It should be interesting to identify what the
original function of this ancestral chemokine gene could
have been. The function of the CXCR4-CXCL12 pair in the
zebrafish in primordial germ cell homing suggests that
chemokines and their receptors first arose as molecules con-
trolling the transit of various cells within organisms simpler
than mammals, and suggests that chemokines and their
receptors have key roles in cellular transit in vivo during
embryogenesis and/or in the adult organism. Another area
of intense research is the function of chemokines in the
development and function of the central nervous system
[24]. This primary function in cellular traffic in vivo also
supports a role for chemokines in cancer metastasis [25].
Recently, Balabanian et al. [26] reported the identification of
a second human receptor (RDC-1) that binds CXCL12, the
characterization of this receptor is on going, but it may also
bind CXCL11. The sequence and characteristics of this recep-
tor indicates that it belongs to the CXC receptor family and,
as such, it should be named CXCR7. Its expression is more
restricted than that of CXCR4, and it will be interesting to
characterize its function in detail. RDC-1 may have another
ligand [27], however, and it might, therefore, not be specific
for CXCL12. Its capacity to bind CXCL12 suggests that it may
represent another receptor (besides CXCR4) with important
functions even in simpler organisms.
Mini-cluster chemokines and gene translocations
The evolution of the chemokines is an ongoing process,
and there are examples of ligands forming ‘mini-clusters’
as well as major clusters (Figure 2b). One of these includes
the CXCL9, CXCL10 and CXCL11 genes, which are located
in the CXC IP-10 inflammatory cluster (4q21.21). The
chemokines they encode function in T-cell recruitment
through CXCR3 [28] and also in the negative control of
angiogenesis through CXCR3B, an alternatively spliced
variant of CXCR3 [29]. Another mini-cluster includes
CCL19 and  CCL21, which are located in close proximity
(9p13 in human) and whose encoded chemokines share a
receptor, CCR7. Likewise, human CCL17 and  CCL22  are
located in close proximity (16q13 in human) and their
chemokines share a receptor (CCR4). Interestingly,
another protein encoded in the same mini-cluster as CCL17
and  CCL22, CX3CL1 (previously called fractalkine) is
totally different from them: it is a transmembrane-type
chemokine with the CX3C motif (two cysteines separated
by three amino acids) instead of the CC motif and interacts
specifically with CX3CR1 (Figure 1, Table 1). The position
of CX3CL1 is probably due to its translocation from else-
where to between CCL17 and CCL22 (Figure 3b).
Another example of a translocation is CCL27, which maps
in close vicinity to CCL19 and CCL21 (Figure 3b) but does
not share CCR7 with the encoded chemokines (Table 1).
Instead, CCL27 is most similar to CCL28, and they share
CCR10 (Table 1). Thus, it is possible that CCL27 was origi-
nally located in chromosome 5p12 and may have translo-
cated to its present site. Alternatively, the location of the
CCL27 gene could be explained by the fact that the gene
for the  chain of the interleukin 11 receptor is located on
this site but in opposite orientation [30], indicating that
this locus has been subjected to multiple evolutionary
forces. Further evidence that chemokine evolution is
ongoing is provided by XCL1 and XCL2 (previously called
lymphotactin), which are the result of a recent gene dupli-
cation as they only differ by one amino acid [31] and they
share the receptor XCR1 [32] (Figure 3b, Table 1). Another
example (in the mouse) is Ccl21, which is encoded by
three different genes that differ in one amino acid codon
and are expressed in distinct anatomical locations [33].
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Figure 4
Chemokine and chemokine receptor sequences, such as (a) CXCR4, (b) CXCL12 and (c) CXCL8, are highly conserved throughout evolution, from
jawless fish to humans. Identical amino acid residues are highlighted in green; the seven transmembrane regions of the receptors are indicated by black
lines; the four conserved cysteine residues are indicated by dots above the sequences. Species abbreviations: dare, Danio rerio (zebrafish); pema,
Petromyzon marinus (sea lamprey); lafl, Lampetra fluviatilis (European river lamprey). Accession numbers (from GenBank) are as follows: human CXCR4,
NM_003467; zebrafish cxcr4b, NM_131834; sea lamprey cxcr4, AY178969; human CXCL12, NM_000609; zebrafish cxcl12a, NM_178307; zebrafish
cxcl12b, NM_198068; human IL-8, NM_000584; river lamprey CXCL8, AJ231072.
Human CXCL8   MTSKLAVALLAAFLISAALCEGAVLPRSAKELRCQCIKTYSKPFHPKFIKELRV  54
Lafl LFCA-1      MTMNAKLLVVLLALALLGHSQAMSVFGGGRCQCVHVISKFIHPKHFQTMEV  51
Human CXCL8   IESGPHCANTEIIVKL-SDGRELCLDPKENWVQRVVEKFLKRAENS          99
Lafl LFCA-1   IPQSSNCKNVEIIVTMKSTNNQICLNPDAPWVRKVISHILDGAQTPKSTQ     101
Human CXCL12  MNAKVVVVLVLVLTAL--CLSDGKPVSLSYRCPCRFFESHVARANVKHLKILNT  52
Dare cxcl12a  MDLKVIVVVALMAVAIHAPISNAKPISLVERCWCRSTVNTVPQRSIRELKFLHT  54
Dare cxcl12b  MDSKVVALVALLMLAFWSPETDAKPISLVERCWCRSTLNTVPQRSIREIKFLHT  54
Human CXCL12  PNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKALNKRFKM               93
Dare cxcl12a  PNCPFQVIAKLK-NNKEVCINPETKWLQQYLKNAINKMKKAQQQQV          99
Dare cxcl12b  PSCPFQVIAKLK-NNREVCINPKTKWLQQYLKNALNKIKKKRSE            97
Human CXCR4       MEGISIYTSDNYT-EE-MGSGDYDSM-----KE-P-CFREENANFNKIFL  41
Dare cxcr4b        MEFYDSIILDNS-SDS-GSGDYDGE-----EL---CDLSVSNDFQKIFL  39
Pema cxcr4    MAELMHSISLDEADLLPMGLNDTSELEDNPPRPAATA-PTCLA-PSQSFHRVFL  52
Human CXCR4   PTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWA  95
Dare cxcr4b   PTVYGIIFVLGIIGNGLVVLVMGFQKKSKNMTDKYRLHLSIADLLFVLTLPFWA  93
Pema cxcr4    PVVYGLVCLLGFAGNGLILVILTCFTKKRTSSDLYLMHLAAADLLFVLTMPFWA 106
Human CXCR4   VDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRK 149
Dare cxcr4b   VDAVSGWHFGGFLCVTVNMIYTLNLYSSVLILAFISLDRYLAVVRATNSQNLRK 147
Pema cxcr4    VGSATEWVFGNVLCCLVNFTFTVNLASSILLLACISIERYLAIVRATKTDKVRR 160
Human CXCR4   LLAEKVVYVGVWIPALLLTIPDFIFANVSEAD--DRYICDRFYP---NDLWVVV 198
Dare cxcr4b   LLAGRVIYIGVWLPATFFTIPDLVFAKIHNSS--MGTICELTYPQEANVIWKAV 199
Pema cxcr4    KFATKVTCGAVWALSLLLAMPDLVFSHVYIAPLSGHQLCEHVYPESASELWRTS 214
Human CXCR4   FQFQHIMVGLILPGIVILSCYCIIISKLSH-SKGHQ-KRKALKTTVILILAFFA 250
Dare cxcr4b   FRFQHIIIGFLLPGLIILTCYCIIISKLSKNSKGQTLKRKALKTTVILILCFFI 253
Pema cxcr4    LRALHHVLAFALPGIVIVFCYVMVIRTLSQ-LHNHE-KRKALKVVVAIVAAFFV 266
Human CXCR4   CWLPYYIGISIDSFILLEIIKQG-CEFENTVHKWISITEALAFFHCCLNPILYA 303
Dare cxcr4b   CWLPYCAGILVDALTMLNVISHS-CFLEQGLEKWIFFTEALAYFHCCLNPILYA 306
Pema cxcr4    CWLPYNVVTLLDTLMRLDAVVNSDCEMEQRLGVAVAVTEGVGFSHCCFIPVLYA 320
Human CXCR4   FLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS      352
Dare cxcr4b   FLGVRFSKSARNALSISSR-SSHKMLTK-KRGPISSVSTESESSSALTS      353
Pema cxcr4    FVGKKFKENLARLRGCKACVGTPVASYREGKRQSSNRPHPISSDSDFSTSTIPA 374
(a) CXCR4
(b) CXCL12
(c) CXCL8Of mice and men
The mouse is generally considered a valuable model for
human diseases. The completion of the mouse genome sup-
ports this view, because it seems to be remarkably similar to
the human genome [34]. Analysis of the human and mouse
genomes has revealed that the genes involved in immune
and host defense roles are under positive selection pressure,
accumulating amino acid changes more rapidly than other
genes. Chemokines are listed as one of the eight most rapidly
changing proteins and domains [35]. Examination of the
gene organization of human and mouse chemokine clusters
also shows great divergence (Figure 3) [36]. The following
are three important differences.
First, some chemokine genes exist in one species but not the
other. This is the most dramatic example of lack of correla-
tion between species and applies specifically to the inflam-
matory/cluster chemokines. Table 1 and Figure 3a show
that, in the CXC subfamily, CXCL8 does not have a mouse
counterpart, whereas Cxcl15 exists in the mouse but not in
human. Among the CC subfamily (Figure 3b), CCL13 and
CCL14 exist in the human but not in the mouse. Alterna-
tively, a given gene in one species (for example, CCL16 and
CCL18) may be represented by a pseudogene in the other.
Second, a given chemokine may be related to (or represented)
by more than one ortholog in the other species (Table 1). This
is due to independent duplication events that have occurred
in one of the species. Human XCL1 and XCL2 and the varying
number copies of human CCL3 and CCL4 and of mouse
Ccl27, Ccl19 and Ccl21 described above are examples of this.
Third, there can be similar genes in the two species but they
may not be ‘exact’ structural or functional equivalents. One
of the best examples of the latter is the MCP group. Struc-
turally, it is difficult to assign a human counterpart unam-
biguously to each mouse gene, because they are all closely
related molecules that probably arose independently in each
species (Figure 2a).
Differences like these may result in important differences in the
function of chemokines between species. These potential differ-
ences do not, however, exclude the mouse as a valid model for
human disease. But they do mean that there are limitations to
the extrapolations we can make when using mouse models to
understand human disease. It is worth emphasizing that these
differences may be particularly important in studies of inflam-
matory diseases, which involve the inflammatory chemokines
(most of which are major-cluster cytokines), and less so in
experiments designed to understand the function of homeosta-
tic chemokines, which, because they are generally noncluster
cytokines and thus more conserved between species, should be
more readily applicable to the human system.
The progress in the discovery and characterization of
chemokines has been remarkable, and we are approaching
the completion of the discovery phase of many other molecu-
lar superfamilies. The sudden availability of so many new
molecules is an excellent opportunity for understanding the
roles of chemokines, not only in the immune system, but
also in development and general physiology. Analysis of the
syntenic genomic regions between mouse and human has
enabled investigation of the relationships between the
chemokines of these species. The mouse is a popular model
for investigating gene function, but it is important that the
significant differences in the chemokine ligand superfamily
between mouse and human are taken into account, espe-
cially as the ability to extrapolate mouse data to human
disease depends on the gene under study. This type of analy-
sis should be applicable to other molecular superfamilies. It
is our hope that the issues we have discussed here will facili-
tate understanding of the biology of the chemokine super-
family.
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